Final Recommendation Statement: Screening for Lung Cancer

Final Recommendation Statement: Screening for Lung Cancer

Final Recommendation Statement: Screening for Lung Cancer

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 12/31/2013 08:00 AM EST

The U.S. Preventive Services Task Force released today a final Recommendation Statement on screening for lung cancer. To view the recommendation and the evidence on which it is based, please go tohttp://www.uspreventiveservicestaskforce.org/uspstf13/lungcan/lungcanfinalrs.htm. A fact sheet that explains the final recommendation in plain language is also available. The final Recommendation Statement can also be found in the December 31 online issue of Annals of Internal Medicine.  

National Guideline Clearinghouse | The role of liver resection in colorectal cancer metastases. Cancer Care Ontario

National Guideline Clearinghouse | The role of liver resection in colorectal cancer metastases.

Cancer Care Ontario 

December 30, 2013

Guideline Title

The role of liver resection in colorectal cancer metastases.

Bibliographic Source(s)

Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, McLeod RS, Expert Panel. The role of liver resection in colorectal cancer metastases. Toronto (ON): Cancer Care Ontario (CCO); 2012 Jun 15. 44 p. (Evidence-based series; no. 17-7).  [86 references]

Guideline Status

This is the current release of the guideline.

The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site  for details on any new evidence that has emerged and implications to the guidelines.

National Guideline Clearinghouse | Stem cell transplantation in primary systemic amyloidosis. Cancer Care Ontario

full-text ►
National Guideline Clearinghouse | Stem cell transplantation in primary systemic amyloidosis.

Cancer Care Ontario

December 30, 2013

Guideline Title Stem cell transplantation in primary systemic amyloidosis. Bibliographic Source(s) Kouroukis CT, Rumble RB. Stem cell transplantation in primary systemic amyloidosis. Toronto (ON): Cancer Care Ontario (CCO); 2012 Mar 29. Various p. (Recommendation report; no. SCT-2).  [7 references] Guideline Status This is the current release of the guideline. The RECOMMENDATION REPORT, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities. Please visit the Cancer Care Ontario Web site  for details on any new evidence that has emerged and implications to the guidelines.

National Guideline Clearinghouse | Stem cell transplantation in myelodysplastic syndromes and acute myeloid leukemia. Cancer Care Ontario

full-text ►
National Guideline Clearinghouse | Stem cell transplantation in myelodysplastic syndromes and acute myeloid leukemia.

Cancer Care Ontario

December 30, 2013

Guideline Title Stem cell transplantation in myelodysplastic syndromes and acute myeloid leukemia. Bibliographic Source(s) Kouroukis CT, Rumble RB, Walker I, Bredeson C, Schuh A. Stem cell transplantation in myelodysplastic syndromes and acute myeloid leukemia. Toronto (ON): Cancer Care Ontario (CCO); 2012 Mar 29. Various p. (Recommendation report; no. SCT-3).  [35 references] Guideline Status This is the current release of the guideline. The RECOMMENDATION REPORT, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities. Please visit the Cancer Care Ontario Web site  for details on any new evidence that has emerged and implications to the guidelines.

National Guideline Clearinghouse | Stem cell transplantation in multiple myeloma. Cancer Care Ontario

full-text ►
National Guideline Clearinghouse | Stem cell transplantation in multiple myeloma.


Cancer Care Ontario

December 30, 2013

Guideline Title

Stem cell transplantation in multiple myeloma.

Bibliographic Source(s)

Kouroukis CT, Rumble RB. Stem cell transplantation in multiple myeloma. Toronto (ON): Cancer Care Ontario (CCO); 2012 Mar 29. Various p. (Recommendation report; no. SCT-1).  [16 references]

Guideline Status

This is the current release of the guideline.

The RECOMMENDATION REPORT, initially the full original Guideline, over time will expand to contain new information emerging from the reviewing and updating activities.

Please visit the Cancer Care Ontario Web site  for details on any new evidence that has emerged and implications to the guidelines.

National Guideline Clearinghouse | Safe administration of systemic cancer therapy. Part 1: safety during chemotherapy ordering, transcribing, dispensing, and patient identification. Cancer Care Ontario

full-text ►
National Guideline Clearinghouse | Safe administration of systemic cancer therapy. Part 1: safety during chemotherapy ordering, transcribing, dispensing, and patient identification.

Cancer Care Ontario

December 30, 2013

Guideline Title

Safe administration of systemic cancer therapy. Part 1: safety during chemotherapy ordering, transcribing, dispensing, and patient identification.

Bibliographic Source(s)

Leung M, Bland R, Baldassarre F, Green E, Kaizer L, Hertz S, Craven J, Trudeau M, Boudreau A, Cheung M, Singh S, Kukreti V, White R, Safe Administration of Systemic Cancer Treatment Expert Panel. Safe administration of systemic cancer therapy. Part 1: safety during chemotherapy ordering, transcribing, dispensing, and patient identification. Toronto (ON): Cancer Care Ontario (CCO); 2012 Jul 9. 75 p. (Evidence-based series; no. 12-12-1).  [65 references]

Guideline Status

This is the current release of the guideline.

The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities.

Please visit the Cancer Care Ontario Web site  for details on any new evidence that has emerged and implications to the guidelines.

National Guideline Clearinghouse | Risk reduction of prostate cancer with drugs or nutritional supplements. Cancer Care Ontario

full-text ►
National Guideline Clearinghouse | Risk reduction of prostate cancer with drugs or nutritional supplements.


Cancer Care Ontario

December 30, 2013

Guideline Title Risk reduction of prostate cancer with drugs or nutritional supplements. Bibliographic Source(s) Fleshner N, Ivers N, Lukka H, Shayegan B, Walker-Dilks C, Winquist E, Genitourinary Cancer Disease Site Group. Risk reduction of prostate cancer with drugs or nutritional supplements. Toronto (ON): Cancer Care Ontario (CCO); 2012 May 17. Various p. (Evidence-based series; no. 3-3).  [75 references] Guideline Status This is the current release of the guideline. The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities. Please visit the Cancer Care Ontario Web site  for details on any new evidence that has emerged and implications to the guidelines.